Thermosensitive heparin-Pluronic® copolymer as effective dual anticancer drugs delivery system for combination cancer therapy
by Nhat-Anh N. Tong; Ngoc Quyen Tran; Xuan Thi Diem Trinh Nguyen; Van Du Cao; Thi Phuong Nguyen; Cuu Khoa Nguyen
International Journal of Nanotechnology (IJNT), Vol. 15, No. 1/2/3, 2018

Abstract: In recent years, cancer therapy regimens combining dual drugs have proved their effectiveness in comparison with single drug. To increase efficacy of these anticancer drugs, an emerging approach involving the development of nanocarriers for dual anticancer drugs delivery has recently received much attention. In the study, thermosensitive Pluronic^®-conjugated heparin was prepared to encapsulate and control the delivery of aquated cisplatin (CDDP) and 5-fluorouracil (5-FU) chemotherapeutic agents. The drug delivery system was determined to be in the size range of 80-100 nm by TEM and 260 nm by DLS. Formation of the complex was confirmed by ¹H-NMR and FT-IR. The nanocomplexes exhibited high drug loading capacity (approximately 9.01% wt/wt of CDDP and 88.24% wt/wt of 5-FU). In vitro, drug-loaded nanogels showed slow and sustained release of the drugs over a long period of time at physiological pH and body temperature. Moreover, the cytotoxicity assay results also indicated that Hep-F127 was cytocompatible. Meanwhile, CDDP-5FU-Hep-F127 nanocomplexes show a significantly inhibited NCI-H460 lung cancer cell growth with the IC50 1.23 ± 0.07 µg/mL. The in vitro preliminary results indicate that the Hep-F127 nanocomplex is a candidate for suitable CDDP and 5-FU delivery which can be studied further in cancer therapy.

Online publication date: Tue, 30-Jan-2018

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Nanotechnology (IJNT):
Login with your Inderscience username and password:

Username:        Password:          Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com